‌

US Patent 10711034 Integrated continuous manufacturing of therapeutic protein drug substances

Patent 10711034 was granted and assigned to Genzyme on July, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Genzyme

Current Assignee

Genzyme

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

107110340

Date of Patent

July 14, 2020

Patent Application Number

154935230

Date Filed

April 21, 2017

Patent Citations Received

‌

US Patent 12110312 Integrated continuous manufacturing of therapeutic protein drug substances

‌

US Patent 11369703 Sterile chromatography resin and use thereof in manufacturing processes

‌

US Patent 11839861 Sterile chromatography resin and use thereof in manufacturing processes

‌

US Patent 11912739 Sterile chromatography and manufacturing processes

‌

US Patent 10919021 Sterile chromatography resin and use thereof in manufacturing processes

Patent Primary Examiner

‌

Marsha Tsay

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10711034 Integrated continuous manufacturing of therapeutic protein drug substances

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API